Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin Dosing Schedules in Spontaneous Bacterial Peritonitis
NCT02528097Terminated
- Sponsor
- NYU Langone Health
- Start
- Sep 2010
- Primary completion
- Jan 2015
- Countries
- 1
01
Overview
Randomised, open-label trial of albumin (human) in spontaneous bacterial peritonitis (SBP), sponsored by NYU Langone Health. Primary endpoint: Renal Failure. Started Sep 2010; status: terminated.
02
Drugs
albumin (human)
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT02528097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02528097.